drugset / Trial / NCT03213457
A Clinical Study to Evaluate the Safety and Efficacy of Elagolix in Participants With Moderate to Severe Endometriosis-Associated Pain
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The objective of this study is to evaluate safety and efficacy of elagolix in the management of moderate to severe endometriosis-associated pain in adult premenopausal female participants including the safety and efficacy of elagolix in combination with concomitant hormonal add-back therapy.
Timeline
- Start
- 2017-07-07
- Primary completion
- 2020-03-27
- Completion
- 2023-12-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Elagolix | Small molecule | 200 mg | — |
| Subject | Estradiol/Norethindrone Acetate | Unknown | 0.5 mg | — |
| Subject | Estradiol/Norethindrone Acetate | Unknown | 1 mg | — |